These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32444910)

  • 1. ASO Author Reflections: Advances in the Multidisciplinary Management of Intrahepatic Cholangiocarcinoma.
    Cloyd JM; Ejaz A; Pawlik TM
    Ann Surg Oncol; 2020 Aug; 27(8):2866-2867. PubMed ID: 32444910
    [No Abstract]   [Full Text] [Related]  

  • 2. Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma.
    Ruff SM; Diaz DA; Pitter KL; Hartwell BC; Pawlik TM
    CA Cancer J Clin; 2023; 73(4):346-352. PubMed ID: 37046405
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholangiocarcinoma: preventing invasion as anti-cancer strategy.
    Gores GJ
    J Hepatol; 2003 May; 38(5):671-3. PubMed ID: 12713880
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Common, Proliferative, and Inflammatory Subtypes of Intrahepatic Cholangiocarcinoma.
    Alaimo L; Moazzam Z; Pawlik TM
    Ann Surg Oncol; 2023 Mar; 30(3):1404-1405. PubMed ID: 36376572
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Incorporating Circulating Tumor DNA in Perioperative Management of Intrahepatic Cholangiocarcinoma.
    Choi WJ; Sapisochin G; O'Kane GM
    Ann Surg Oncol; 2023 Jun; 30(6):3864-3865. PubMed ID: 36752965
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholangiocarcinoma: current concepts and insights.
    Gores GJ
    Hepatology; 2003 May; 37(5):961-9. PubMed ID: 12717374
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Identification of Intrahepatic Cholangiocarcinoma Clusters Using Machine Learning Techniques: Should Patients be Treated Differently?
    Tsilimigras DI; Paredes AZ; Pawlik TM
    Ann Surg Oncol; 2020 Dec; 27(13):5233-5234. PubMed ID: 32591955
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Intrahepatic Cholangiocarcinoma: Downstaging Strategies Open the Gate to Surgery and Cure.
    Boudjema K; Edeline J
    Ann Surg Oncol; 2020 Oct; 27(10):3738-3739. PubMed ID: 32314152
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical pathology of cholangiocarcinoma (intrahepatic bile duct cancer)].
    Yamamoto M
    Nihon Geka Hokan; 1995 Nov; 64(6):129-30. PubMed ID: 8913088
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Classification of Intrahepatic Cholangiocarcinoma into Perihilar versus Peripheral Subtype.
    Wei T; Zhang XF; Pawlik TM
    Ann Surg Oncol; 2024 Feb; 31(2):1274-1275. PubMed ID: 37993744
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Disparate Outcomes in Stage II Intrahepatic Cholangiocarcinoma: A Case for Upstaging Multifocal Tumors.
    Turner KM; Wilson GC
    Ann Surg Oncol; 2022 Aug; 29(8):5103-5104. PubMed ID: 35482267
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Use of Machine Learning to Predict Early Recurrence After Resection of Intrahepatic Cholangiocarcinoma.
    Alaimo L; Pawlik TM
    Ann Surg Oncol; 2023 Sep; 30(9):5416-5417. PubMed ID: 37222944
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Accuracy of Preoperative Staging and Downstaging After Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma.
    Alaimo L; Lima HA; Moazzam Z; Pawlik TM
    Ann Surg Oncol; 2023 Aug; 30(8):4809-4810. PubMed ID: 37046130
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: A New Reliable Method of Evaluating Cancer-Associated Fibroblasts in Resected Specimen of Intrahepatic Cholangiocarcinoma.
    Eguchi S; Yamada D; Kobayashi S; Sasaki K; Iwagami Y; Tomimaru Y; Noda T; Takahashi H; Asaoka T; Tanemura M; Doki Y; Eguchi H
    Ann Surg Oncol; 2023 Sep; 30(9):5429-5430. PubMed ID: 37273026
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Adequate Nodal Classification for Perihilar Cholangiocarcinoma.
    Sakata J; Takizawa K; Miura K; Hirose Y; Muneoka Y; Tajima Y; Ichikawa H; Shimada Y; Kobayashi T; Wakai T
    Ann Surg Oncol; 2023 Jul; 30(7):4318-4319. PubMed ID: 37000358
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status in Patients with Intrahepatic Cholangiocarcinoma.
    Endo Y; Moazzam Z; Lima HA; Pawlik TM
    Ann Surg Oncol; 2023 Apr; 30(4):2033-2034. PubMed ID: 36396871
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Monitoring the Risk of Recurrence After Curative-Intent Liver Resection for Intrahepatic Cholangiocarcinoma by Applying Hazard Function Analysis.
    Alaimo L; Moazzam Z; Pawlik TM
    Ann Surg Oncol; 2023 Mar; 30(3):1350-1351. PubMed ID: 36006495
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Long-Term Outcomes and Optimal Margin Width Among Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma.
    Alaimo L; Moazzam Z; Pawlik TM
    Ann Surg Oncol; 2023 Jul; 30(7):4302-4303. PubMed ID: 36964330
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Usage of Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma.
    Holster JJ; Groot Koerkamp B
    Ann Surg Oncol; 2022 Sep; 29(9):5539-5540. PubMed ID: 35266080
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Robotic Approach for Perihilar Cholangiocarcinoma.
    Ielpo B; Rosso E; d'Addetta MV; Abad M; Vellalta G; Sanchez-Velazquez P; Burdio F
    Ann Surg Oncol; 2024 May; 31(5):3106-3107. PubMed ID: 38334849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.